Lack of association between endometriosis and the CYP17 MspA1 polymorphism in UK and Japanese populations

Gynecological Endocrinology

Volumn 20, Issue 2, 2005, Pages 59-63

  Asghar, Tasneem ^a   Yoshida, Shigeki ^a   Nakago, Satoshi ^a   Morizane, Mayumi ^a   Ohara, Norita ^a   Motoyama, Satoru ^a   Kennedy, Stephen ^b   Barlow, David ^b   Maruo, Takeshi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CYP17; Endometriosis; Gene polymorphism

Indexed keywords

CYTOCHROME P450 17; ESTROGEN; GENOMIC DNA; RESTRICTION ENDONUCLEASE; RESTRICTION ENDONUCLEASE MSPA1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASIAN; BLOOD SAMPLING; CAUCASIAN; CONTROLLED STUDY; DNA ISOLATION; ELECTROPHORESIS; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STEROIDOGENESIS; UNITED KINGDOM;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DNA; DNA PRIMERS; ENDOMETRIOSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; JAPAN; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; STEROID 17-ALPHA-HYDROXYLASE;

EID: 18044383361     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590400020856     Document Type: Article

References (29)

1. Wheeler JM. Epidemiology of endometriosis-associated infertility. J Reprod Med 1989;34:41-46.
2. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997;24:235-258.
3. Zondervan KT, Cardon LR, Kennedy SH. The genetic basis of endometriosis. Curr Opin Obstet Gynecol 2001;13:309-314.
4. Kennedy SH. The genetics of endometriosis. Eur J Obstet Gynecol Reprod Biol 1999;82:129-133.
5. Bulun SE, Zeitoun KM, Takayama K, Sasabo H. Molecular basis for treating endometriosis with aromatase inhibitors. Hum Reprod Update 2000;6:413-418.
6. Carey AH, Waterworth D, Patel K, White D, Little J, Novelli P, Franks S, Williamson R. Polycystic ovaries and premature male baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994;3:1873-1876.
7. Feigelson HS, Shames LS, Pike MC, Coetzee GA, Stanczyk FZ, Henderson BE. Cytochrome P450 17α gene (CYP17) polymorphism is associated with serum estrogen and progestrone concentrations. Cancer Res 1998;58:585-587.
8. Lunn RM, Bell DA, Mohler JL, Taylor JA. Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2). Carcinogensis 1999;20:1727-1731.
9. Gsur A, Bernhofer G, Hinteregger S, Haidinger G, Schatzl G, Madersbacher S, Marberger M, Vutuc C, Micksche M. A polymorphism in the CYP17 gene is associated with prostate cancer risk. Int J Cancer 2000;87:434-437.
10. Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 1997;57:1063-1065.
11. Kado N, Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Tsukamoto K, Hasegawa G, Nakamura N, Yoshikawa T, et al. Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women. Hum Reprod 2002;17:897-902.
12. Revised American Society for Reproductive Medicine Classification of endometriosis 1996. Fertil Steril 1997;67:817-821.
13. Young IE, Kurian KM, Annink C, Kunkler IH, Anderson VA, Cohen BB, Hooper ML, Wyllie AH, Steel CM. A polymorphism in the CYP17 gene is associated with male breast cancer. Br J Cancer 1999;81:141-143.
14. Dunning AM, Healey CS, Pharoah PD, Foster NA, Lipscombe JM, Redman KL, Easton DF, Day NE, Ponder BA. No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. Br J Cancer 1998;77:2045-2047.
15. Feigelson HS, McKean-Cowdin R, Pike MC, Coetzee GA, Kolonel LN, Nomura AM, Le Marchand L, Henderson BE. Cytochrome P450c17α gene (CYP17) polymorphism predicts use of hormone replacement therapy. Cancer Res 1999;59:3908-3910.
16. Hadfield RM, Manek S, Nakago S, Mukherjee S, Weeks DE, Mardon HJ, Barlow DH, Kennedy SH. Absence of a relationship between endometriosis and the N314D polymorphism of galactose-1-phosphate uridyl transferase in a UK population. Mol Hum Reprod 1999;5:990-993.
17. Nakago S, Hadfield RM, Zondervan KT, Mardon H, Manek S, Weeks DE, Barlow D, Kennedy S. Association between endometriosis and N-acetyl transferase 2 polymorphism in a UK population. Mol Hum Reprod 2001;7:1079-1083.
18. Stefansson H, Einarsdottir A, Geirsson RT, Jonsdottir K, Sverrisdottir G, Gudnadottir VG, Gunnarsdottir S, Manolescu A, Gulcher J, Stefansson K. Endometriosis is not associated with or linked to the GALT gene. Fertil Steril 2001;76:1019-1022.
19. Zondervan KT, Cardon LR, Kennedy SH. What makes a good case-control study?: design issues for complex traits such as endometriosis. Hum Reprod 2002;17:1415-1423.
20. Allene NE, Forrest MS, Key TJ. The association between polymorphisms in the CYP17 and 5α-reductase (SRD5A2) genes and serum androgen concentrations in men. Cancer Epidemiol Biomarkers Prev 2001;10:185-189.
21. Kennedy S, Bennett S, Weeks DE. Affected sib-pair analysis in endometriosis. Hum Reprod Update 2001;7:411-418.
22. Treloar SA, Hadfield R, Montgomery G, Lambert A, Wicks J, Barlow DH, O'Connor DT, Kennedy SH, and the International Endogene Study Group. The International Endogene Study: a collection of families for genetic research in endometriosis. Fertil Steril 2002;78:679685.
23. Rier SE, Martin DC, Bowman RE, Dmowski WP, Becker JL. Endometriosis in rhesus monkeys (Macaca mulatto) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol 1993;21:433-441.
24. Baranov VS, Ivaschenko T, Bakay B, Aseev M, Belotserkovskaya R, Baranova H, Malet P, Perriot J, Mouraire P, Baskakov VN, et al. Proportion of the GSTM1 0/0 genotype in some Slavic populations and its correlation with cystic fibrosis and some multifactorial diseases. Hum Genet 1996;97:516-520.
25. Baranova H, Bothorishvilli R, Canis M, Albuisson E, Perriot S, Glowaczower E, Bruhat MA, Baranov V, Malet P. Glutathione S-transferase Ml gene polymorphism and susceptibility to endometriosis in a French population. Mol Hum Reprod 1997;3:775-780.
26. Baranova H, Canis M, Ivaschenko T, Albuisson E, Bothorishvilli R, Baranov V, Malet P, Bruhat MA. Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis. Mol Hum Reprod 1999;5:636-641.
27. Georgiou I, Syrrou M, Bouba I, Dalkalitsis N, Paschopoulos M, Navrozoglou I, Lolis D. Association of estrogen receptor gene polymorphisms with endometriosis. Fertil Steril 1999; 72:164-166.
28. Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Kado N, Tsukamoto K, Hasegawa G, Nakamura N, Honjo H. Oestrogen receptor alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. Hum Reprod 2001;16:51-55.
29. Cramer DW, Hornstein MD, Ng WG, Barbieri RL. Endometriosis associated with the N314D mutation of galactose-1-phosphate uridyl transferase (GALT). Mol Hum Reprod 1996;2:149-152.